Bath & Body Works Grows to 25% of Limited's Value
Below, we take a quick look at the outlook for the two main drivers to our Bath & Body Works forecast: its U.S. sales per square foot, and its EBITDA margins.
Bath & Body Works U.S. Stores at a Glance
Bath & Body Works caters to the complete well being of customers by providing shower gels and lotions, aromatherapy, antibacterial soaps, candles and personal care accessories. The core of Bath & Body Works offerings are its Signature Collection, antibacterial and home fragrance product lines, which together make up the majority of its sales and profits.
The key drivers of profitability for Bath & Body Works stores in U.S. include:
The average annual revenue per square foot of BBW stores in U.S. decreased from $697 in 2006 to $587 in 2009 before rising to about $600 in 2010. The three-year decline primarily resulted from falling sales due to weak store traffic and the challenging economic environment. BBW U.S. stores' revenue per square foot increased in 2010 from the low of 2009 as the economic environment improved and store traffic increased.
Going forward, we believe the revenue per square foot for Bath & Body Works stores in the U.S. will grow at a constant rate reaching almost $800 by the end of our forecast period.
We estimate that EBITDA margin for BBW stores in the U.S. decreased from 20% in 2005 to just under 12% in 2008. The decrease was attributable to two factors: First, a decline in stores' gross profit margins due to higher expenses and increased promotional activities designed to drive sales, and second, higher general, administrative and store operating expenses.
In 2010, the EBITDA margin for BBW stores in the U.S. increased to over 20%, due primarily to an increase in gross profit driven by a better sales mix, which helped gross margins, as well as lower operating expenses. Going forward, we estimate Bath & Body Works US stores' EBITDA margin will remain constant at current levels through the Trefis forecast period.
Our price estimate for Limited Brands' stock stands at $33.36, which is about 20% below the market price, though if sales and profit margins improve beyond our forecast, there could be upside to these forecasts. You can see these by modifying the charts above.
Trefis is an online investment research platform targeted towards individual and professional investors. Trefis also includes a community of users that can create and share their models and analysis on trefis.com.Like our charts? Embed them in your own posts using the Trefis Wordpress Plugin.